Cracker King Corp.
Letter data
- Company
- Cracker King Corp.
- Recipient
- Cracker King Corp. | United States
- Issue date
- 2018-07-09
- Posted date
- Not available
- FDA office
- United States
- Subject
- Not available
- Product
- Not available
- CMS ID
- 528052
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Cracker King Corp.
MARCS-CMS 528052 —
July 09, 2018
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Recipient:
Cracker King Corp.
United States
Issuing Office:
United States
Office of Human and Animal Food Operations East
Division 1
UNITED PARCEL SERVICE
SIGNATURE REQUIRED
July 9, 2018
Mr. Leonardo C. Morales, President
Cracker King Corp.
307 Peninsula Blvd
Hempstead, NY 11550-4912
Dear Mr. Morales:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter [CMS 528052, September 15, 2017]. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
CDR Catherine M. Beer
Director of Compliance
Office of Human and Animal Food Operations
East – Division 1
Content current as of:
07/25/2018